Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order
BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, announces that further to its press release dated December 20, 2022, the Company and its auditors are continuing to work diligently to complete the audit of the Company’s annual ... Read More
